Smith & Nephew (SN) Shares Down 0.5%
Smith & Nephew plc (LON:SN) traded down 0.5% on Tuesday . The stock traded as low as GBX 1,278.50 ($17.34) and last traded at GBX 1,278.50 ($17.34). 2,556,648 shares traded hands during mid-day trading, an increase of 16% from the average session volume of 2,200,000 shares. The stock had previously closed at GBX 1,285 ($17.43).
Several research firms have recently commented on SN. Berenberg Bank reissued a “hold” rating and set a GBX 1,340 ($18.17) target price on shares of Smith & Nephew in a research report on Friday, November 3rd. Jefferies Group reissued a “buy” rating and set a GBX 1,515 ($20.55) target price on shares of Smith & Nephew in a research report on Monday, November 6th. Citigroup reissued a “sell” rating and set a GBX 1,160 ($15.73) target price on shares of Smith & Nephew in a research report on Thursday, October 12th. JPMorgan Chase & Co. reissued a “neutral” rating and set a GBX 1,361 ($18.46) target price on shares of Smith & Nephew in a research report on Tuesday, October 10th. Finally, Goldman Sachs Group reissued a “neutral” rating and set a GBX 1,380 ($18.71) target price on shares of Smith & Nephew in a research report on Monday, September 11th. One analyst has rated the stock with a sell rating, eight have assigned a hold rating and two have assigned a buy rating to the stock. The company presently has an average rating of “Hold” and a consensus price target of GBX 1,315.82 ($17.84).
The stock has a market cap of $11,180.00 and a price-to-earnings ratio of 1,775.69.
COPYRIGHT VIOLATION NOTICE: This news story was published by Watch List News and is the property of of Watch List News. If you are viewing this news story on another website, it was illegally copied and republished in violation of U.S. & international copyright & trademark laws. The original version of this news story can be read at https://www.watchlistnews.com/smith-nephew-sn-shares-down-0-5/1800203.html.
Smith & Nephew Company Profile
Smith & Nephew plc is a medical technology company. The Company is engaged in developing, manufacturing, marketing and selling medical devices and services. Its products and services include Sports Medicine Joint Repair, Arthroscopic Enabling Technologies (AET), Trauma & Extremities, Other Surgical Businesses, Knee Implants, Hip Implants, Advanced Wound Care, Advanced Wound Bioactives and Advanced Wound Devices.
Receive News & Ratings for Smith & Nephew Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Smith & Nephew and related companies with MarketBeat.com's FREE daily email newsletter.